Does ADALIMUMAB Cause Hemiparesis? 232 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 232 reports of Hemiparesis have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.1% of all adverse event reports for ADALIMUMAB.
232
Reports of Hemiparesis with ADALIMUMAB
0.1%
of all ADALIMUMAB reports
8
Deaths
156
Hospitalizations
How Dangerous Is Hemiparesis From ADALIMUMAB?
Of the 232 reports, 8 (3.4%) resulted in death, 156 (67.2%) required hospitalization, and 27 (11.6%) were considered life-threatening.
Is Hemiparesis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 232 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause Hemiparesis?
ASPIRIN (538)
FINGOLIMOD (534)
METHOTREXATE (534)
RIVAROXABAN (363)
PREDNISONE (359)
METFORMIN (353)
DIMETHYL (345)
RITUXIMAB (331)
CLOPIDOGREL BISULFATE (327)
ATORVASTATIN (317)
Which ADALIMUMAB Alternatives Have Lower Hemiparesis Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB